The specific localization of advanced glycation end-products (AGEs) in rat pancreatic islets

Yuta Morioka, Kiyoshi Teshigawara, Yasuko Tomono, Dengli Wang, Yasuhisa Izushi, Hidenori Wake, Keyue Liu, Hideo Kohka Takahashi, Shuji Mori, Masahiro Nishibori

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Advanced glycation end-products (AGEs) are produced by non-enzymatic glycation between protein and reducing sugar such as glucose. Although glyceraldehyde-derived AGEs (Glycer-AGEs), one of the AGEs subspecies, have been reported to be involved in the pathogenesis of various age-relating diseases such as diabetes mellitus or arteriosclerosis, little is known about the pathological and physiological mechanism of AGEs in vivo. In present study, we produced 4 kinds of polyclonal antibodies against AGEs subspecies and investigated the localization of AGEs-modified proteins in rat peripheral tissues, making use of these antibodies. We found that Glycer-AGEs and methylglyoxal-derived AGEs (MGO-AGEs) were present in pancreatic islets of healthy rats, distinguished clearly into the pancreatic α and β cells, respectively. Although streptozotocin-induced diabetic rats suffered from remarkable impairment of pancreatic islets, the localization and deposit levels of the Glycer- and MGO-AGEs were not altered in the remaining α and β cells. Remarkably, the MGO-AGEs in pancreatic β cells were localized into the insulin-secretory granules. These results suggest that the cell-specific localization of AGEs-modified proteins are presence generally in healthy peripheral tissues, involved in physiological intracellular roles, such as a post-translational modulator contributing to the secretory and/or maturational functions of insulin.

Original languageEnglish
Pages (from-to)218-224
Number of pages7
JournalJournal of Pharmacological Sciences
Volume134
Issue number4
DOIs
Publication statusPublished - Aug 1 2017

Fingerprint

Advanced Glycosylation End Products
Islets of Langerhans
Pyruvaldehyde
Glyceraldehyde
Insulin
Proteins
Antibodies
Arteriosclerosis
Secretory Vesicles
Streptozocin
Diabetes Mellitus
Glucose

Keywords

  • Advanced glycation end products (AGEs)
  • Glyceraldehyde-derived AGEs (Glycer-AGEs)
  • Methylglyoxal-derived AGEs (MGO-AGEs)
  • Pancreatic alpha cells
  • Pancreatic beta cells

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

The specific localization of advanced glycation end-products (AGEs) in rat pancreatic islets. / Morioka, Yuta; Teshigawara, Kiyoshi; Tomono, Yasuko; Wang, Dengli; Izushi, Yasuhisa; Wake, Hidenori; Liu, Keyue; Takahashi, Hideo Kohka; Mori, Shuji; Nishibori, Masahiro.

In: Journal of Pharmacological Sciences, Vol. 134, No. 4, 01.08.2017, p. 218-224.

Research output: Contribution to journalArticle

Morioka, Yuta ; Teshigawara, Kiyoshi ; Tomono, Yasuko ; Wang, Dengli ; Izushi, Yasuhisa ; Wake, Hidenori ; Liu, Keyue ; Takahashi, Hideo Kohka ; Mori, Shuji ; Nishibori, Masahiro. / The specific localization of advanced glycation end-products (AGEs) in rat pancreatic islets. In: Journal of Pharmacological Sciences. 2017 ; Vol. 134, No. 4. pp. 218-224.
@article{3ec908fa1828477dbb73f412815eb1c9,
title = "The specific localization of advanced glycation end-products (AGEs) in rat pancreatic islets",
abstract = "Advanced glycation end-products (AGEs) are produced by non-enzymatic glycation between protein and reducing sugar such as glucose. Although glyceraldehyde-derived AGEs (Glycer-AGEs), one of the AGEs subspecies, have been reported to be involved in the pathogenesis of various age-relating diseases such as diabetes mellitus or arteriosclerosis, little is known about the pathological and physiological mechanism of AGEs in vivo. In present study, we produced 4 kinds of polyclonal antibodies against AGEs subspecies and investigated the localization of AGEs-modified proteins in rat peripheral tissues, making use of these antibodies. We found that Glycer-AGEs and methylglyoxal-derived AGEs (MGO-AGEs) were present in pancreatic islets of healthy rats, distinguished clearly into the pancreatic α and β cells, respectively. Although streptozotocin-induced diabetic rats suffered from remarkable impairment of pancreatic islets, the localization and deposit levels of the Glycer- and MGO-AGEs were not altered in the remaining α and β cells. Remarkably, the MGO-AGEs in pancreatic β cells were localized into the insulin-secretory granules. These results suggest that the cell-specific localization of AGEs-modified proteins are presence generally in healthy peripheral tissues, involved in physiological intracellular roles, such as a post-translational modulator contributing to the secretory and/or maturational functions of insulin.",
keywords = "Advanced glycation end products (AGEs), Glyceraldehyde-derived AGEs (Glycer-AGEs), Methylglyoxal-derived AGEs (MGO-AGEs), Pancreatic alpha cells, Pancreatic beta cells",
author = "Yuta Morioka and Kiyoshi Teshigawara and Yasuko Tomono and Dengli Wang and Yasuhisa Izushi and Hidenori Wake and Keyue Liu and Takahashi, {Hideo Kohka} and Shuji Mori and Masahiro Nishibori",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.jphs.2017.07.005",
language = "English",
volume = "134",
pages = "218--224",
journal = "Journal of Pharmacological Sciences",
issn = "1347-8648",
publisher = "The Japanese Pharmacological Society",
number = "4",

}

TY - JOUR

T1 - The specific localization of advanced glycation end-products (AGEs) in rat pancreatic islets

AU - Morioka, Yuta

AU - Teshigawara, Kiyoshi

AU - Tomono, Yasuko

AU - Wang, Dengli

AU - Izushi, Yasuhisa

AU - Wake, Hidenori

AU - Liu, Keyue

AU - Takahashi, Hideo Kohka

AU - Mori, Shuji

AU - Nishibori, Masahiro

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Advanced glycation end-products (AGEs) are produced by non-enzymatic glycation between protein and reducing sugar such as glucose. Although glyceraldehyde-derived AGEs (Glycer-AGEs), one of the AGEs subspecies, have been reported to be involved in the pathogenesis of various age-relating diseases such as diabetes mellitus or arteriosclerosis, little is known about the pathological and physiological mechanism of AGEs in vivo. In present study, we produced 4 kinds of polyclonal antibodies against AGEs subspecies and investigated the localization of AGEs-modified proteins in rat peripheral tissues, making use of these antibodies. We found that Glycer-AGEs and methylglyoxal-derived AGEs (MGO-AGEs) were present in pancreatic islets of healthy rats, distinguished clearly into the pancreatic α and β cells, respectively. Although streptozotocin-induced diabetic rats suffered from remarkable impairment of pancreatic islets, the localization and deposit levels of the Glycer- and MGO-AGEs were not altered in the remaining α and β cells. Remarkably, the MGO-AGEs in pancreatic β cells were localized into the insulin-secretory granules. These results suggest that the cell-specific localization of AGEs-modified proteins are presence generally in healthy peripheral tissues, involved in physiological intracellular roles, such as a post-translational modulator contributing to the secretory and/or maturational functions of insulin.

AB - Advanced glycation end-products (AGEs) are produced by non-enzymatic glycation between protein and reducing sugar such as glucose. Although glyceraldehyde-derived AGEs (Glycer-AGEs), one of the AGEs subspecies, have been reported to be involved in the pathogenesis of various age-relating diseases such as diabetes mellitus or arteriosclerosis, little is known about the pathological and physiological mechanism of AGEs in vivo. In present study, we produced 4 kinds of polyclonal antibodies against AGEs subspecies and investigated the localization of AGEs-modified proteins in rat peripheral tissues, making use of these antibodies. We found that Glycer-AGEs and methylglyoxal-derived AGEs (MGO-AGEs) were present in pancreatic islets of healthy rats, distinguished clearly into the pancreatic α and β cells, respectively. Although streptozotocin-induced diabetic rats suffered from remarkable impairment of pancreatic islets, the localization and deposit levels of the Glycer- and MGO-AGEs were not altered in the remaining α and β cells. Remarkably, the MGO-AGEs in pancreatic β cells were localized into the insulin-secretory granules. These results suggest that the cell-specific localization of AGEs-modified proteins are presence generally in healthy peripheral tissues, involved in physiological intracellular roles, such as a post-translational modulator contributing to the secretory and/or maturational functions of insulin.

KW - Advanced glycation end products (AGEs)

KW - Glyceraldehyde-derived AGEs (Glycer-AGEs)

KW - Methylglyoxal-derived AGEs (MGO-AGEs)

KW - Pancreatic alpha cells

KW - Pancreatic beta cells

UR - http://www.scopus.com/inward/record.url?scp=85028319164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028319164&partnerID=8YFLogxK

U2 - 10.1016/j.jphs.2017.07.005

DO - 10.1016/j.jphs.2017.07.005

M3 - Article

VL - 134

SP - 218

EP - 224

JO - Journal of Pharmacological Sciences

JF - Journal of Pharmacological Sciences

SN - 1347-8648

IS - 4

ER -